Historical record - last NADAC publication: 4/17/2019

Product Information

THERAFLU EXPRESSMAX DAY CAPLET is a brand product labeled by Haleon US Holdings LLC, priced at $0.2601 per EA under NDC 00067813620. Its NADAC has been published 161 times since Mar 22, 2017.

The High Outlier badge above means this manufacturer's average price in the acetaminophen, dextromethorphan HBr, phenylephrine HCl market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

THERAFLU EXPRESSMAX DAY CAPLET

acetaminophen, dextromethorphan HBr, phenylephrine HCl
$0.2601per EA
High Outlier
OTC

Strength

325; 10; 5 mg/1; mg/1; mg/1

NDC

00067813620

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/17/2019

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

7/5/2016

Pharmacological Classes

Adrenergic alpha1-Agonists
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price Statistics

The NADAC for THERAFLU EXPRESSMAX DAY CAPLET has been published 161 times since Mar 22, 2017, and over the history we have for it it has declined 5.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2601 per EA
All-time high$0.2742 (Apr 12, 2017)
All-time low$0.2529 (Mar 20, 2019)
Median price$0.2612
Average price$0.2638
Largest weekly change-4.0% (Mar 21, 2018)
Weeks tracked161
Tracking sinceMar 22, 2017

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

-5.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the acetaminophen, dextromethorphan HBr, phenylephrine HCl market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of THERAFLU EXPRESSMAX DAY CAPLET?

The current National Average Drug Acquisition Cost (NADAC) for THERAFLU EXPRESSMAX DAY CAPLET, manufactured by Haleon US Holdings LLC, is $0.2601 per EA (NDC 00067813620), effective Apr 15, 2020.

How has the price of THERAFLU EXPRESSMAX DAY CAPLET changed over time?

Over the history we have for it, the NADAC for THERAFLU EXPRESSMAX DAY CAPLET has declined 5.1%. It has been tracked across 161 weekly CMS publications since Mar 22, 2017.

What are the highest and lowest recorded NADAC prices for THERAFLU EXPRESSMAX DAY CAPLET?

Since Mar 22, 2017, the NADAC for THERAFLU EXPRESSMAX DAY CAPLET has ranged from a low of $0.2529 (Mar 20, 2019) to a high of $0.2742 (Apr 12, 2017), with a median of $0.2612 per EA.

Are there cheaper alternatives to THERAFLU EXPRESSMAX DAY CAPLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of THERAFLU EXPRESSMAX DAY CAPLET, so no direct lower-cost alternative is listed.

Who manufactures THERAFLU EXPRESSMAX DAY CAPLET?

THERAFLU EXPRESSMAX DAY CAPLET (NDC 00067813620) is labeled by Haleon US Holdings LLC, and CMS classifies it as a brand product.